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Abstract
Seizures or convulsions that occur during anaesthesia in veterinary patients are infrequently reported in the litera-
ture. Consequently, the incidence of such events is unknown. Several drugs commonly used in clinical veterinary
anaesthesia have been shown to induce epileptiform activity in both human clinical patients and experimental
candidates. The present case report describes convulsions in a four-year old male Bernese mountain dog during
maintenance of anaesthesia with isoflurane after premedication with acepromazine and methadone followed by
co-induction with propofol and ketamine. The dog had no history of previous convulsions. The use of several seda-
tive and anaesthetic drugs makes it difficult to find one single causative pharmaceutical.
Background
The classification of abnormal motor activity in veterin-
ary patients is unclear. The international league against
epilepsy (ILAE) guidelines have been used, with various
modifications, as a basis for classification of seizure
types in dogs [1] An epileptic seizure involves, according
to ILEA a clinically manifested event with a corrobora-
tive EEG abnormality, and the clinical observed state is
described as a convulsion [2]. A genetic background for
canine epilepsy has been described in several breeds
including the Bernese Mountain Dog [1,3]. Seizures or
convulsions in conjunction with clinical veterinary
anaesthesia are infrequently reported in the literature,
and the incidence of such events or their relation to
genetic susceptibility for epilepsy is not known. Several
drugs commonly applied in clinical veterinary anaesthe-
sia may induce epileptiform activity in human clinical
patients and in experimental studies [2]. Multimodal
analgesia and inducing anaesthesia with more than one
drug have become increasingly popular over the last
years, leading to the use of a wide range of drug combi-
nations in small animal anaesthesia [4-6]. This case
report describes convulsions in a dog during isoflurane
anaesthesia after premedication with acepromazine and
methadone followed by co-induction with propofol and
ketamine.
Case presentation
A four years old male Bernese mountain dog weighing
45 kg underwent general anaesthesia for arthroscopy of
the left stifle joint and a tibia plateau levelling osteot-
omy of the same leg. The dog had no previous history
of disease, and a preanaesthetic physical examination
revealed no abnormalities except from a ruptured cra-
nial cruciate ligament on the left hind leg. Ten days
earlier the dog had been sedated for a radiological
examination of the left stifle joint with 0.36 mg/kg of
xylazine given intravenously without any noticeable
adverse effects. On the day of surgery, the dog was pre-
medicated with an intramuscular injection of 50 μg/kg
acepromazine (Plegicil Vet 10 mg/ml, Pharmaxin, Hel-
singborg, Sweden) and methadone 0.1 mg/kg (Metadon
10 mg/ml, Sykehusapoteket Rikshospitalet, Oslo,
Norway). An 18 gauge intravenous catheter (Becton
Dickinson, Helsingborg, Sweden) was placed in the left
cephalic vein. General anaesthesia was induced by an
intravenous injection of ketamine 2 mg/kg (Ketalar 50
mg/ml, Pfizer Inc, New York, USA) immediately fol-
lowed by an intravenous injection of propofol (Propofol-
Lipuro 10 mg/ml, B. Braun, Melsungen, Germany) given
through the intravenous catheter to facilitate endotra-
cheal intubation. The dog was placed in right lateral
recumbency and allowed to breathe spontaneously.
Anaesthesia was maintained with isoflurane (Isoba Vet.,
Schering Plough, Ballerup Denmark) in an equal mix-
ture of oxygen and air delivered by means of a circle
patient breathing system connected to an anaesthetic
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machine (Matrx. Medical Inc., Orchard Park, NY, USA).
The dog received an infusion of Ringers acetate (Ringer
Acetate, Fresenius Kabi, Halden Norway) at 10 ml/kg/
hour. A multi-parameter-anaesthetic monitor (Datex
Ohmeda S/5 compact anesthesia monitor, Datex-
Ohmeda Instrumentarium corp., Finland) was used
to continuously monitor systolic, diastolic and mean
arterial blood pressure, a 3-lead electrocardiogram,
SpO2, FiO2, ETCO2, ET isoflurane (ETiso) and rectal
temperature.
Approximately 10 minutes after induction of anaesthe-
sia the dog displayed clonic muscular activity of the
front limbs and head, including paddling of the front
limbs and twitching of lips and eye lids. Concurrently
heart rate and respiratory rate increased from 102/min
to 126/min and 17/min to 47/min respectively. ETiso
concentration at this point was 1.0 Vol%. Midazolam
(Midazolam 5 mg/ml, B. Braun, Melsungen, Germany)
0.1 mg/kg was administered intravenously and the
inspired isoflurane fraction (Fiiso) was increased. This
resulted in cessation of the convulsions. An arterial
blood sample was simultaneously collected and analysed
using an automated blood gas analyser (ABL 800 Flex,
Radiometer Copenhagen, Brønshøj, Denmark). The
blood gas analysis revealed a respiratory alkalosis with a
pH of 7.533, a PaCO2 of 2.64 kPa and a base excess of -
4.0 mmol/l, but no abnormalities in PaO2, ionised cal-
cium, sodium, potassium, chloride, lactate, glucose or
haemoglobin concentrations.
Convulsive activity as previously described resumed
again after about 10 minutes from the first occurrence.
ETiso was now 1.5 Vol%. Heart rate again increased
from 100/min to 125/min and the respiratory rate
increased to 59/min after a period of apnoea during
which the dog was ventilated manually. At this point,
body temperature measured rectally was 35.6°C. ETiso
was decreased to1.1 Vol%. Midazolam 0.1 mg/kg was
administered i.v. without apparent effect upon the con-
vulsions. Thiopental (Pentothal Natrium 500 mg, Hos-
pira Ent., Hoofddorp, Netherlands) 1 mg/kg i.v was
administered twice. The convulsions continued, and
phenobarbital (Fenobarbital natrium NAF 100 mg/ml,
NAF, Oslo, Norway) 4 mg/kg was given i.v. followed by
a third dose of thiopental at 1 mg/kg. At this point the
convulsions subsided 45 minutes after the first convul-
sions started. Isoflurane delivery was discontinued and
the dog was allowed to recover. Thirty minutes after
discontinuing isoflurane delivery the dog had had
no further convulsions, and was lying in sternal
recumbency.
The following day a neurological examination was per-
formed and a blood sample was also analysed, including
a complete blood count and a full biochemical evalua-
tion, without revealing any abnormalities. Two days
after the first anaesthesia it was decided to anaesthetise
the dog a second time to perform the procedure not
undertaken due to the described adverse event. An
intravenous catheter was placed and general anaesthesia
was induced by injection of 0.4 mg/kg of midazolam
combined with fentanyl (Fentanyl Hameln 50 μg/ml,
Hameln Pharmaceuticals, Hameln, Germany) until intu-
bation was possible. The dog was endotracheally intu-
bated, and anaesthesia was maintained by an infusion of
fentanyl at 20-40 μg/kg/h and midazolam at 0.2-0.3 mg/
kg/h. The dogs ventilation was controlled using an auto-
matic ventilator throughout the anaesthesia to maintain
normocapnia. A lumbosacral epidural injection of 0.2
ml/kg 0.5% bupivacaine (Marcain 5 mg/ml, AstraZeneca,
Södertälje, Sweden) was performed. After starting sur-
gery sevoflurane (Sevoflo, Abbott lab, Kent, Great Brit-
ain) was added to the mixture of oxygen and air to
achieve end tidal sevoflurane concentration of 0.9 - 1.5
Vol%. No convulsive activity was observed and the dog
recovered uneventfully from anaesthesia. Ten months
after the incidence during anaesthesia the dog was
behaving normal according to the owner, no further
sedative or anaesthetic drug has been given the dog, and
no further convulsions or seizures had been observed.
Discussion
This case report describes myoclonic convulsive activity
in a dog following administration of several sedative and
anaesthetic drugs making it difficult to point out one
single causative factor. Acepromazine has been cited in
the literature to cause a lowering of seizure threshold in
dogs, and it has been stated that it should be avoided in
dogs with a history of epilepsy or convulsions [7]. Ali-
phatic phenothiazines such as chlorpromazine have
been shown to reduce seizure threshold in dogs and
humans. In dogs with a history of seizures without
known underlying disease, a rapid intravenous injection
of 2.2 mg/kg chlorpromazine potentiated or induced
EEG changes in 22 of 43 dogs and precipitated seizures
in two of the dogs [8]. In a study from 1967, a higher
incidence of seizures was found in psychiatric patients
without a history of epilepsy treated with chlorproma-
zine (25 to over 1000 mg/day) than the incidence of a
first unprovoked seizure in the general population (0.07-
0.09%) [9]. The incidence of seizures following the use
of phenothiazines is unknown in canine patients. In a
recent study, 27 of 31 dogs with a known history of sei-
zures did not display seizure activity in an observational
period after treatment with acepromazine. The majority
of these dogs had however received antiepileptic medi-
cations prior to treatment [10]. In a second retrospective
study, acepromazine did not increase the risk of seizures
in dogs with a history of seizures due to different aetiol-
ogies, and was also used to treat seizure activity
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successfully [11]. The dose of acepromazine adminis-
tered in the current case and in the studies describing
use in dogs with a history of seizures are more than a
tenfold lower than the dose of chlorpromazine cited to
cause EEG changes in dogs, while the route of adminis-
tration varies between the different cases described. This
could account for some of the discrepancy between the
reports. Whether acepromazine contributed to the
development of seizures or not in the current case
remains unknown.
NMDA receptor blockade should theoretically be able
to ameliorate epileptiform activity [12] and as such,
ketamine has been used to treat refractory status epilep-
ticus in humans and a dog [13]. Ketamine at higher
doses has on the other hand been associated with con-
vulsions, increased muscle tone and spontaneous mus-
cular activity in dogs [14]. It has also been advised
that ketamine should not be used in animals with pre-
existing seizure disorders [15]. Although the evidence is
conflicting, ketamine is probably a better anticonvulsant
than a proconvulsant when used with a GABA-agonist
[2,16]. The time elapsed from injection of ketamine to
the onset of the abnormal muscle activity was about 10
to 12 minutes in the described case; this corresponds
with the time span where maximal motor side effects
are described to present in dogs when ketamine is given
alone [14]. In a previous study using lower doses of
ketamine for co-induction of anaesthesia with propofol,
none of the dogs displayed convulsions or seizures after
ketamine administration. The examiners did not find a
difference in motor side effects in dogs administered the
combination of ketamine and propofol compared to
when propofol was used alone for induction of anaes-
thesia [4]. In human patients the use of ketamine com-
bined with propofol for induction of anaesthesia
reduced the incidence of excitatory effects significantly
in comparison to use of propofol alone [17]. The fact
that the dose of ketamine chosen in the present case
was relatively low and that it was used for co-induction
of anaesthesia with the GABA agonist propofol after
premedication with acepromazine makes it less likely
that ketamine was responsible for the convulsions
observed.
A number of neurological complications including
abnormal motor activity have been associated with the
use of propofol for induction and maintenance of gen-
eral anaesthesia in human patients [18]. Abnormal
motor activity in conjunction with the use of propofol
for induction and maintenance of anaesthesia has also
been described in dogs, with a reported incidence
between 7.5 to 25%, and with clinical signs such as tre-
mor, tics, muscular rigidity of the forelimbs, swimming
movements, opisthotonus and nystagmus most common
[19-21]. Paradoxically, propofol has depressant effects
on the central nervous system involving GABA, gluta-
mate and aspartate mechanisms [22], and has been used
successfully as an anticonvulsant in human and veterin-
ary patients with seizures [23,24]. Although the onset of
the clinical signs was delayed, propofol could be respon-
sible for the signs displayed by the dog in this case
report. A late onset of clinical signs up to 30 minutes
after the end of propofol anaesthesia has been described
in human patients [18], and propofol has a prolonged
terminal elimination half life in dogs and humans, lead-
ing to significant concentrations of propofol in the ner-
vous system for some time after injection [25,26].
Volatile anaesthetics have been associated with induc-
tion of abnormal EEG changes, seizures or abnormal
muscular activity in humans and other species, although
a difference seems to be present between agents regard-
ing their pro- and anticonvulsant potentials [2,2,27].
Enflurane is known to produce EEG changes and clini-
cal signs of abnormal muscular activity in dogs, while
sevoflurane was not found to induce seizure activity
[28]. The epileptogenic effect of sevoflurane, although
controversial, has been frequently reported in humans.
The effect might be dose related and can be precipitated
by hypocapnia [29]. In the described case, a peri-MAC
concentration of isoflurane was used to maintain anaes-
thesia as abnormal muscular activity occurred. The inci-
dence of seizures during isoflurane anaesthesia is
controversial [30], but seizures during recovery have
been reported in humans [31]. The nonconvulsant
effects of isoflurane, seem, however, to be more impor-
tant [2], and isoflurane has been used successfully in the
treatment of status epilepticus in human patients [32].
The role of isoflurane in the current case is not known,
but a contribution to the development of convulsions
can not be excluded.
The dog described in this case report had no previous
history of convulsions, neither were signs of disease
found during the pre-anaesthetic examination nor after
a neurological examination and blood analysis. A predis-
position of idiopathic epilepsy seems to be present in
the Bernese mountain dog [3], and underlying disease
can not be excluded as a contributing cause of the
observed clinical signs.
Diazepam, phenobarbital and pentobarbital have all
been suggested for the treatment if severe signs develop
in conjunction with the use of propofol in dogs [20,25].
This is a similar approach to the one applied to control
clinical signs in the present case, where benzodiazepines
and barbiturates combined with discontinuation of
anaesthesia seemed to alleviate signs of abnormal mus-
cular activity.
The choice of protocol for the second anaesthesia in
the present dog was based on exclusion of the drugs
used during the first anaesthesia, and the usage of drugs
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known to have little potential of causing abnormal mus-
cular activity in dogs, humans and other species. Mida-
zolam is a benzodiazepine, that acts mainly on the a
GABAA subunit and is known to be strongly anticonvul-
sant [2]. On the other hand, dogs that receive midazo-
lam alone may show signs of agitation or increased
excitement [5,33]. Mu-agonistic opioids can cause sei-
zures in human patients [2], but at the same time fenta-
nyl has been shown to reduce the occurrence of
epileptiform spike waves during sevoflurane anaesthesia
in humans [34]. An end, tidal concentration of sevoflur-
ane well below the published MAC for dogs was used to
maintain anaesthesia in the current case [35]. This cor-
responds to recommendations made for the use of sevo-
flurane in human patients to minimise the epileptogenic
potential of sevoflurane [29]. The anaesthetic regime
used for this second anaesthesia seemed to be successful
in preventing development of abnormal muscular activ-
ity. However, EEG monitoring was not performed and
epileptiform activity could have been present without
clinical signs. Phenobarbital has a long terminal half life
in dogs [36], and a persisting anticonvulsant effect of
the injection given 2 days earlier can not be entirely
excluded.
Conclusions
This case report describes convulsions in a dog during
anaesthesia achieved by use of multiple drugs for
balanced anaesthesia used to minimise side effects.
Treatment with benzodiazepines and barbiturates com-
bined with discontinuation of anaesthesia could success-
fully be used to stop convulsions, and a second
anaesthetic procedure was successfully performed by
excluding all drugs used in the first anaesthetic proce-
dure and choosing drugs known to have a low potential
of causing convulsions in humans and dogs. The use of
multiple drugs during anaesthesia has several advan-
tages, but can also make it difficult to point out a single
causative pharmaceutical if unwanted effects occur.
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